Live Breaking News & Updates on Decipher Prostate Biopsy

Stay updated with breaking news from Decipher prostate biopsy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Veracyte, Inc. (NASDAQ:VCYT) Director Karin Eastham Sells 2,500 Shares

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) Director Karin Eastham sold 2,500 shares of the stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $20.97, for a total transaction of $52,425.00. Following the completion of the transaction, the director now directly owns 33,125 shares of […] ....

United States , William Blair , Karin Eastham , Lazard Asset Management , National Bancorp , Morgan Stanley , Goldman Sachs Group , Sg Americas Securities , Financial Services Group Inc , Needham Company , Veracyte Inc , Get Free Report , Director Karin Eastham , Asset Management , Services Group , Aigen Investment Management , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,

Veracyte, Inc. (NASDAQ:VCYT) Director Muna Bhanji Sells 1,539 Shares

Veracyte, Inc. (NASDAQ:VCYT) Director Muna Bhanji Sells 1,539 Shares
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Muna Bhanji , Goldman Sachs Group , Lazard Asset Management , National Bancorp , Veracyte Inc , Morgan Stanley , Financial Services Group Inc , Needham Company , Sg Americas Securities , Get Free Report , Director Muna Bhanji , Asset Management , Services Group , Aigen Investment Management , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,

Veracyte, Inc. (NASDAQ:VCYT) Receives $27.50 Average Price Target from Brokerages

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average twelve-month price target […] ....

United States , William Blair , Karin Eastham , Veracyte Inc , Securities Exchange Commission , Investment Management , Morgan Stanley , Nikko Asset Management Americas Inc , Needham Company , Dimensional Fund Advisors , Goldman Sachs Group , Veracyte Company Profile , Sumitomo Mitsui Trust Holdings Inc , Vanguard Group Inc , Get Free Report , Marketbeat Ratings , Director Karin Eastham , Exchange Commission , Fund Advisors , Mitsui Trust Holdings , Nikko Asset Management Americas , Asset Management Americas , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy ,

Brokerages Set Veracyte, Inc. (NASDAQ:VCYT) PT at $27.50

Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 12 […] ....

United Kingdom , United States , William Blair , Karin Eastham , Goldman Sachs Group , Investment Management , United Kingdom Plc , Veracyte Inc , Morgan Stanley , Qube Research Technologies Ltd , Needham Company , Get Free Report , Marketbeat Ratings , Director Karin Eastham , Forest Capital Management , Technologies Ltd , Kingdom Plc , Stock Down , Get Free , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,

Needham & Company LLC Lowers Veracyte (NASDAQ:VCYT) Price Target to $27.00

Needham & Company LLC Lowers Veracyte (NASDAQ:VCYT) Price Target to $27.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , William Blair , Karin Eastham , Needham Company , Veracyte Inc , Morgan Stanley , China Universal Asset Management Co , Assetmark Inc , Sg Americas Securities , Financial Services Group Inc , National Bancorp , Veracyte Company Profile , Goldman Sachs Group , Free Report , Moderate Buy , Get Free Report , Director Karin Eastham , Universal Asset Management , Services Group , Afirma Genomic Sequencing Classifier , Decipher Prostate Biopsy , Radical Prostatectomy , Prosigna Breast Cancer Assay , Percepta Nasal Swab Test , Envisia Genomic Classifier , Veracyte Daily ,